gantenerumab

A year after Roche's Alzheimer's failure, scientists reflect on what could have been
Fierce Biotech
Wed, 11/15/23 - 11:49 pm
Roche
Genentech
Alzheimer's disease
gantenerumab
CTAD 2022 – gantenerumab’s shortcomings keep amyloid hypothesis alive
EP Vantage
Thu, 12/1/22 - 10:28 am
Roche
clinical trials
CTAD
Alzheimer's disease
gantenerumab
Roche Failure Leaves Industry Reassessing Alzheimer's Space
BioSpace
Wed, 11/16/22 - 10:45 am
Roche
Alzheimer's disease
gantenerumab
Biogen
Cassava Sciences
Eli Lilly
Trial failures end latest hope for Roche’s Alzheimer’s drug
BioPharma Dive
Mon, 11/14/22 - 10:57 am
Roche
Alzheimer's disease
gantenerumab
clinical trials
Roche CEO Cautious on Alzheimer’s Trial Despite Eisai’s Success
Bloomberg
Wed, 10/19/22 - 10:35 am
Roche
Pharma CEOs
Severin Schwan
Alzheimer's disease
Eisai
gantenerumab
lecanemab
Roche, Biogen temper Alzheimer’s expectations in Q2 calls. Will Lilly follow suit in August?
Fierce Biotech
Fri, 07/22/22 - 11:21 am
Alzheimer's disease
Roche
Biogen
Eli Lilly
lecanemab
gantenerumab
Aduhelm
20 years in, Genentech persists and perseveres in Alzheimer's with gantenerumab
Fierce Biotech
Wed, 04/6/22 - 07:44 pm
Roche
Genentech
Alzheimer's disease
gantenerumab
A trio of amyloid-targeted Alzheimer's drugs will soon see key results, but an analyst predicts only 50-50 odds for one
Endpoints
Wed, 03/9/22 - 11:09 pm
Alzheimer's disease
clinical trials
Roche
Eli Lilly
Biogen
donanemab
lecanemab
gantenerumab
Roche starts new four-year trial of Alzheimer’s drug gantenerumab
Pharmaforum
Fri, 03/4/22 - 09:48 am
Roche
Alzheimer's disease
clinical trials
gantenerumab
3 Clinical Trials to Watch in the First Half of 2022
Motley Fool
Sat, 01/22/22 - 02:20 pm
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Roche
Alzheimer's disease
gantenerumab
AbbVie
cystic fibrosis
10 clinical trials to watch in the first half of 2022
BioPharma Dive
Mon, 01/3/22 - 10:46 am
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Sanofi
GSK
vaccines
COVID-19
Roche
gantenerumab
AbbVie
Gilead Sciences
Trodelvy
Karuna Therapeutics
KarXT
Intercept Pharma
obeticholic acid
Allogene
ALLO-501a
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
Motley Fool
Sun, 11/28/21 - 11:03 pm
Roche
Biogen
Alzheimer's disease
Aduhelm
gantenerumab
Alzheimer’s Drug Granted FDA Breakthrough Designation as Space Heats Up
BioSpace
Mon, 10/11/21 - 09:48 pm
Roche
FDA
breakthrough therapy
Alzheimer's disease
gantenerumab
Roche's Gantenerumab Gets FDA Breakthrough Therapy Designation for Alzheimer's Disease
Marketwatch
Sat, 10/9/21 - 10:58 pm
Roche
FDA
gantenerumab
Alzheimer's disease
breakthrough therapy
Roche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readout
Pharmaforum
Thu, 07/22/21 - 11:05 am
Roche
FDA
Alzheimer's disease
gantenerumab
Roche to seek early FDA approval for Alzheimer’s therapy: Jefferies
Seeking Alpha
Thu, 07/1/21 - 10:45 am
Roche
FDA
Alzheimer's disease
gantenerumab
Roche's Alzheimer's antibody lowers biomarkers in inherited form of disease, though impact on symptoms is unclear
Fierce Biotech
Mon, 06/21/21 - 11:08 am
Roche
gantenerumab
Alzheimer's disease
clinical trials
biomarkers
Roche refreshingly cautious on Alzheimer's hopeful gantenerumab amid growing hype from rivals
Fierce Biotech
Fri, 02/5/21 - 10:52 am
Roche
gantenerumab
Alzheimer's disease
Lilly and Roche's antibodies fail late-phase Alzheimer's test
Fierce Biotech
Mon, 02/10/20 - 10:17 am
Eli Lilly
Roche
Alzheimer's disease
clinical trials
solanezumab
gantenerumab
Roche’s gantenerumab fails to meet primary endpoint in AD trial
Pharmaceutical Business Review
Mon, 02/10/20 - 10:08 am
Roche
gantenerumab
Alzheimer's disease
clinical trials

Pages